α-Fetoprotein Impairs APC Function and Induces Their Apoptosis
Author(s) -
Soon Ho Um,
Catherine Mulhall,
Akeel Alisa,
Annette Ives,
John Karani,
Roger Williams,
Antonio Bertoletti,
Shahriar Behboudi
Publication year - 2004
Publication title -
the journal of immunology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.737
H-Index - 372
eISSN - 1550-6606
pISSN - 0022-1767
DOI - 10.4049/jimmunol.173.3.1772
Subject(s) - cd86 , apoptosis , cd40 , immune system , tumor necrosis factor alpha , hepatocellular carcinoma , alpha fetoprotein , cytokine , cancer research , immunology , medicine , ex vivo , in vivo , biology , in vitro , t cell , cytotoxic t cell , biochemistry , microbiology and biotechnology
alpha-Fetoprotein (AFP) is a tumor-associated Ag, and its serum level is elevated in patients with hepatocellular carcinoma (HCC). In vitro, AFP induces functional impairment of dendritic cells (DCs). This was demonstrated by the down-regulation of CD40 and CD86 molecules and the impairment of allostimulatory function. Also, AFP was found to induce significant apoptosis of DCs, and AFP-treated DCs produced low levels of IL-12 and TNF-alpha, a cytokine pattern that could hamper an efficient antitumor immune response. Ex vivo, APCs of patients with HCC and high levels of AFP produced lower levels of TNF-alpha than that of healthy individuals. In conclusion, these results illustrate that AFP induces dysfunction and apoptosis of APCs, thereby offering a mechanism by which HCC escapes immunological control.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom